Group 1 - The fourth meeting of the board of directors of Meirui New Materials Co., Ltd. was held on August 23, 2025, with all seven directors present, confirming the legality and validity of the meeting [2][3] - The board approved the proposal for capital increase to Meirui Technology to enhance its financial strength and alleviate liquidity pressure, aligning with the company's strategic development plan [4] - The capital increase will result in an increased shareholding ratio for the company in Meirui Technology, which remains a consolidated subsidiary, and will not significantly impact the company's operational and financial status [4]

Group 1 - The company held its 22nd meeting of the 5th Board of Directors on August 22, 2025, with all 9 directors present, ensuring compliance with relevant laws and regulations [1] - The Board unanimously approved the full text and summary of the 2025 semi-annual report, confirming that it accurately reflects the company's financial status and operational conditions without any false statements or omissions [1][2] - The financial report section was reviewed and approved by the company's Audit Committee in its third meeting of 2025 [2] Group 2 - The Board also unanimously approved the special report on the storage and usage of raised funds for the first half of 2025, confirming compliance with relevant laws and regulations without any significant issues [2] - The Board agreed on the provision for asset impairment, stating that it aligns with accounting standards and reflects the company's actual situation, enhancing the fairness of the financial statements [2]

Meeting Overview - The second board meeting of King Kai (Liaoning) Life Science Co., Ltd. was held on August 22, 2025, with all 7 directors present, including 2 via communication [1] - The meeting was chaired by Chairman Fumin Wang and complied with relevant laws and regulations [1] Financial Reporting - The board approved the 2025 semi-annual report, confirming it accurately reflects the company's financial status and operational results without any misleading statements [2] - The report on the management and use of raised funds was also approved, indicating compliance with regulations and accurate reporting [2] Compensation Adjustments - The board agreed to adjust the independent director's allowance from 100,000 yuan to 120,000 yuan per year, effective upon shareholder approval [3] Fund Management - The board approved a change in the method of using raised funds from loans to capital injection into subsidiaries, aimed at improving fund efficiency and protecting shareholder interests [3] - The use of idle raised funds for cash management was also approved, ensuring it does not affect project construction or normal operations [5] Governance Enhancements - The board approved revisions to the company's articles of association and internal governance rules to enhance corporate governance and protect investor rights [6][7] - New internal governance systems were established to further improve the company's governance structure [9] Capital Injection - The board approved the use of self-owned funds to increase capital in Kingchem Life Science LLC for the construction of Kingchem Laboratories Inc., supporting the company's international competitiveness [10] Upcoming Meetings - The company plans to hold its first temporary shareholders' meeting on September 22, 2025, combining on-site and online voting [10]

证券代码：600508 证券简称：上海能源 编号：临 2025-026 上海大屯能源股份有限公司 第九届董事会第八次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 公司第九届董事会第八次会议于 2025 年 8 月 21 日在公司行 政研发中心附楼 317 会议室召开。应到董事 8 人，实到 8 人，董 事长张付涛先生、副董事长李跃文先生、董事刘广东先生、朱世 艳女士、独立董事吴娜女士现场参加会议；董事吴凤东先生、独 立董事朱凤山先生、朱义军先生以视频方式参加会议。公司部分 高级管理人员及有关人员列席了会议，符合《公司法》和《公司 章程》的有关规定，公司董事长张付涛先生主持会议。 会议听取了关于公司 2025 年上半年董事会授权事项行权情 况的汇报，审议并通过以下决议： 一、审议通过关于公司 2025 年半年度报告的议案； 公司 2025 年半年度报告依法在指定信息披露报纸及网站上 披露。 表决结果：同意 8 票，反对 0 票，弃权 0 票。 本议案已经公司第九届董事会审计与风险管理委员会 2025 年第四次会 ...

Core Points - The company held its 37th board meeting on August 22, 2025, with 8 directors present and 7 in attendance, confirming compliance with legal regulations [2] - The board unanimously approved the semi-annual report for the period ending June 30, 2025, with 8 votes in favor and no opposition [2] - The company decided not to distribute an interim dividend for the first half of 2025, with the same unanimous approval [3] Summary by Categories Financial Reports - The board approved the semi-annual report and its summary, as well as the overseas interim performance announcement [2] - The company will not distribute an interim dividend for the first half of 2025 [3] Asset Management - The board approved a proposal for asset impairment provision for the first half of 2025 [2] Governance - The board authorized the company secretary to finalize necessary modifications to the semi-annual report before its release [3] - The board approved the selection management measures for the accounting firm [3] - The board revised the rules for the nomination committee meetings and the diversity policy for board members [4]

证券代码：000045、200045 证券简称：深纺织A、深纺织B 公告编号:2025-25 本议案提交董事会前已经公司第八届董事会审计委员会第二十九次会议审 议通过。 二、以 9 票同意、0 票反对、0 票弃权的表决结果审议通过了《关于变更董 事会秘书的议案》。 内容详见 2025 年 8 月 23 日巨潮资讯网（http://www.cninfo.com.cn）公司 《关于变更董事会秘书的公告》（2025-28 号）。 特此公告 深圳市纺织（集团）股份有限公司 深圳市纺织（集团）股份有限公司 第八届董事会第四十一次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 深圳市纺织（集团）股份有限公司（以下简称"公司"）于 2025 年 8 月 11 日以专人送达和电子邮件的方式发出了召开公司第八届董事会第四十一次会议 的通知，本次董事会会议于 2025 年 8 月 21 日（星期四）上午 10:00 在公司会议 室以现场结合通讯表决方式召开。会议应出席董事 9 人，实际出席董事 9 人，其 中独立董事吴光权、杨高宇、王恺以通讯表决方式出席。会议由董事长尹 ...

Group 1 - The board of directors of Beijing Zhongyi Antu Technology Co., Ltd. held its seventh meeting of the fifth session, with 8 directors present, including some via telecommunication [1] - The board approved the 2025 semi-annual report and its summary, confirming that the report accurately reflects the company's financial status and operational results for the first half of 2025 [1][2] - The board also approved a special report on the storage and use of raised funds, affirming compliance with relevant laws and regulations regarding the management of these funds [2]

Group 1 - The board of directors of Aerospace Rainbow Drone Co., Ltd. held its 28th meeting on August 21, 2025, via communication voting, with all 9 directors participating [1] - The meeting's agenda included the approval of the company's 2025 semi-annual report summary, which will be published on August 22, 2025 [1][2] - The board approved a proposal to apply for a credit limit of 530 million yuan from Aerospace Technology Finance Co., Ltd. for working capital loans and other financial services, with a one-year term [2] Group 2 - The board agreed to revise the company's articles of association, which will be submitted for shareholder approval [3] - The board confirmed that the company has complied with regulations regarding the use of raised funds, with no violations reported [3] - The board nominated candidates for the seventh board of directors, including both non-independent and independent directors, to be voted on at the upcoming shareholder meeting [4] Group 3 - The company plans to hold its second extraordinary general meeting of 2025 on September 9, 2025 [4] - The resumes of the nominated candidates for the seventh board of directors were provided, detailing their qualifications and previous positions [5][6][7][8][9][10][11][12][13]

证券代码：301299 证券简称：卓创资讯 公告编号：2025-035 山东卓创资讯股份有限公司 第三届董事会第十七次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 一、董事会会议召开情况 山东卓创资讯股份有限公司(以下简称"公司")第三届董事会第十七次会 （公告编号：2025-037）和《2025 年半年度报告摘要》 议于 2025 年 8 月 21 日在公司会议室以现场结合通讯方式召开。本次会议通知于 席董事 6 人，独立董事张宜生先生、朱清滨先生均以通讯方式出席。本次会议由 董事长姜虎林先生召集并主持，公司监事和高级管理人员列席会议。本次会议的 召集、召开符合有关法律法规、部门规章、规范性文件和《公司章程》的有关规 定，合法、有效。 二、 董事会会议审议情况 本次会议以现场结合通讯表决的方式，审议并通过以下议案： 表决结果：6 票同意，0 票反对，0 票弃权。 董事会认为，《2025 年半年度报告》全文及其摘要所载内容符合法律法规、 中国证监会和深圳证券交易所的相关规定，报告内容真实、准确，完整地反映了 公司的实际情况，不存在任何虚假记载、 ...

证券代码：605060 证券简称：联德股份 公告编号：2025-032 杭州联德精密机械股份有限公司 杭州联德精密机械股份有限公司（以下简称"公司"）第三届董事会第十三 次会议于 2025 年 8 月 21 日（星期四）在公司二楼会议室以现场的方式召开。会 议通知已于 2025 年 8 月 16 日通过书面的方式送达各位董事。本次会议应出席董 事 8 人，实际出席董事 8 人。 会议由董事长孙袁主持，高级管理人员列席了本次会议。会议召开符合有 关法律、法规、规章和《公司章程》的规定。经各位董事认真审议，会议形成了 如下决议： 二、董事会会议审议情况 第三届董事会第十三次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 具体内容详见公司同日披露于上海证券交易所网站（www.sse.com.cn）的《联 德股份 2025 年半年度报告》及《联德股份 2025 年半年度报告摘要》。 （二）审议通过《关于 2025 年半年度募集资金存放与实际使用情况的专项 报告》 表决结果：8 票同意，0 票反对， ...